Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in Women at High Risk of Breast Cancer
NCT00291694Phase 2Completed
- Start
- Apr 2003
- Primary completion
- Dec 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in breast cancer comparing Celecoxib with Placebo (2 arms). Primary endpoint: Change in Percent of Breast Epithelial Cells Staining Positive for Ki-67 at 12 months. Started Apr 2003; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00291694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00291694.